North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Fluticasone/Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
- Study Title
- Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
- Teva Identifier
- FSS-AS-201
- ClinicalTrials.gov Identifier
- NCT01772368
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Fp MDPI | Drug: FS MDPI | Drug: Advair Diskus | Drug: Albuterol
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 01/01/2013 - 06/01/2013
- Phase
- Phase 2
